PHARMACOLOGICAL CHARACTERIZATION OF TACHYKININ-INDUCED INTRACELLULAR CALCIUM RISE IN A HUMAN NK2 RECEPTOR TRANSFECTED CELL-LINE

被引:6
|
作者
SUBRAMANIAN, N
RUESCH, C
BERTRAND, C
机构
[1] Ciba Geigy Ltd., Dept. Asthma and Allergy, Pharmaceuticals Division
关键词
D O I
10.1006/bbrc.1994.1622
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have examined the effect of various natural and synthetic tachykinins on the steady state Ca++-rise ([Ca++](i)) in transfected chinese hamster ovary cells expressing recombinant human Neurokinin 2 (NK2) receptors. The rank order of potency with natural tachykinins was NeurokininA > Neurokinin B> Eledoisin > Physaelamin > substance P. The selective NK2 agonist, [beta-Ala(8)]NKA(4-10) was very potent,with an EC(50) value of 4.83 x 10(-9)M whereas Senktide, MePhe(7)NKB and Sar(9), (MetO(2))(11) substance P, selective NK3 and NK1 agonists, respectively, did not have any effect on [Ca++](i) in hrNK2CHO cells, suggesting a selective and preferential recognition and activation of NK2 receptors in these cells. (+/-) SR 48968, a selective NK2 antagonist, abolished the beta-AlaNKA-induced [Ca++](i) with an IC50 value of 0.7 nM. Two other peptidic NK2 antagonists, MEN 10376 and L-658977, were less active with IC50 values of 49 nM and 5.29 mu M, respectively. In contrast, (+/-) CP-96,345 and (+/-)CP-99,994 and RP 67580, all selective NK1 antagonists, did not have any effect on the beta-AlaNKA-induced [Ca++](i) in hrNK2CHO cells (+/-) SR 140333, a potent and selective NK1 antagonist,had a 35% inhibition under similar conditions. These data demonstrate a high selectivity and sensitivity to NK2 receptor mediated [Ca++](i) in rhNK2R-CHO cells and may be of value as a rapid, selective test of drug action at the human NK2 receptors in vitro. (C) 1994 Academic Press, Inc.
引用
收藏
页码:1512 / 1520
页数:9
相关论文
共 50 条
  • [1] Occurrence and pharmacological characterization of four human tachykinin NK2 receptor variants
    Ahlstedt, Ingela
    Engberg, Susanna
    Smith, John
    Perrey, Chris
    Moody, Adrian
    Morten, John
    Lagerstrom-Fermer, Maria
    Drmota, Tomas
    von Mentzer, Bengt
    Pahlman, Ingrid
    Lindstrom, Erik
    BIOCHEMICAL PHARMACOLOGY, 2008, 76 (04) : 476 - 481
  • [2] PHYSIOLOGICAL AND PHARMACOLOGICAL CHARACTERIZATION OF THE SPINAL TACHYKININ NK2 RECEPTOR
    LEPRE, M
    OLPE, HR
    EVANS, RH
    BRUGGER, F
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 258 (1-2) : 23 - 31
  • [3] Tachykinin NK2 receptors predominantly mediate tachykinin-induced contractions in ovine trachea
    Reynolds, AM
    Reynolds, P
    Holmes, M
    Scicchitano, R
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 341 (2-3) : 211 - 223
  • [4] MEN 11420 is a potent antagonist at the native and transfected human tachykinin NK2 receptor
    Cucchi, P
    Patacchini, R
    Renzetti, AR
    Maggi, CA
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125
  • [5] NK2 TACHYKININ RECEPTORS AND CONTRACTION OF CIRCULAR MUSCLE OF THE HUMAN COLON - CHARACTERIZATION OF THE NK2 RECEPTOR SUBTYPE
    GIULIANI, S
    BARBANTI, G
    TURINI, D
    QUARTARA, L
    ROVERO, P
    GIACHETTI, A
    MAGGI, CA
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 203 (03) : 365 - 370
  • [6] CHARACTERIZATION OF A TACHYKININ PEPTIDE NK2 RECEPTOR TRANSFECTED INTO MURINE FIBROBLAST B82 CELLS
    VANGIERSBERGEN, PLM
    SHATZER, SA
    HENDERSON, AK
    LAI, J
    NAKANISHI, S
    YAMAMURA, HI
    BUCK, SH
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (05) : 1661 - 1665
  • [7] Characterization of tachykinin NK2 receptor in the anterior pituitary gland
    Pisera, D
    Candolfi, M
    De Laurentiis, A
    Seilicovich, A
    LIFE SCIENCES, 2003, 73 (19) : 2421 - 2432
  • [8] Pharmacological evaluation of α and β human tachykinin NK2 receptor splice variants expressed in CHO cells
    Bellucci, F
    Meini, S
    Catalioto, RM
    Catalani, C
    Giuliani, S
    Quartara, L
    Giolitti, A
    Faiella, A
    Rotondaro, L
    Candenas, ML
    Pinto, FM
    Maggi, CA
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 499 (03) : 229 - 238
  • [9] Expression of tachykinin NK2 receptor mRNA in human brain
    Bensaid, M
    Faucheux, BA
    Hirsch, E
    Agid, Y
    Soubrié, P
    Oury-Donat, F
    NEUROSCIENCE LETTERS, 2001, 303 (01) : 25 - 28
  • [10] NK2 receptors mediate tachykinin-induced contractions of rat uterus during the oestrous cycle
    Moodley, N
    Lau, WAK
    Pennefather, JN
    Story, ME
    Fisher, L
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 376 (1-2) : 53 - 60